RAD51 mutations have been identified in ovarian cancer; specifically, deleterious variants were shown in RAD51B, RAD51C, and RAD51D (nonsense, frameshift, and splice), with a predominance for RAD51C and RAD51D mutations [38]. Here, RAD51D is linked to ovarian carcinoma.